SCHEMBL7365315

SCHEMBL7365315

O=C(O)CCCCCCOc1cccc(-c2ccccc2)c1

nearest known ligand 0.72

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 5/20 0.72
HDAC2 Q92769 5/20 0.72
FFAR4 Q5NUL3 4/20 0.70
FFAR1 O14842 2/20 0.70
HDAC8 Q9BY41 3/20 0.64
HDAC6 Q9UBN7 3/20 0.64
HDAC3 O15379 2/20 0.64
HDAC4 P56524 2/20 0.64
HDAC7 Q8WUI4 2/20 0.64
HDAC10 Q969S8 2/20 0.64
HDAC11 Q96DB2 2/20 0.64
HDAC9 Q9UKV0 2/20 0.64
HDAC5 Q9UQL6 2/20 0.64
FABP1 P07148 1/20 0.64
LTB4R Q15722 4/20 0.59
HRH3 Q9Y5N1 4/20 0.59
LTB4R2 Q9NPC1 1/20 0.56
PPARG P37231 1/20 0.56
PPARA Q07869 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8355650 1.00 HDAC1 (0.72) HDAC1HDAC2FFAR4FFAR1HDAC8
SCHEMBL7044733 0.98 FFAR4 (0.72) HDAC1HDAC2FFAR4FFAR1HDAC8
SCHEMBL7046130 0.94 FFAR4 (0.78) HDAC1HDAC2FFAR4FFAR1HDAC8
SCHEMBL8987102 0.89 LTB4R (0.64) HDAC1HDAC2FFAR4FFAR1HDAC8
SCHEMBL7049369 0.89 FFAR4 (0.67) HDAC1HDAC2FFAR4FFAR1HDAC8
SCHEMBL30639265 0.89 PPARA (0.58) HDAC1HDAC2FFAR4FFAR1FABP1
SCHEMBL7367452 0.88 HDAC1 (0.69) HDAC1HDAC2FFAR4FFAR1HDAC8
SCHEMBL7515225 0.85 HDAC3 (0.77) HDAC1HDAC2FFAR4FFAR1HDAC8
SCHEMBL1007408 0.85 HDAC3 (0.77) HDAC1HDAC2FFAR4FFAR1HDAC8
SCHEMBL3381443 0.85 HDAC3 (0.77) HDAC1HDAC2FFAR4FFAR1HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020177594-A1 Inhibitors of histone deacetylase ABBOTT LABORATORIES 2002-11-28 US disclosed
US-20020103192-A1 Inhibitors of histone deacetylase ABBOTT LABORATORIES 2002-08-01 US disclosed
WO-2002046129-A2 INHIBITORS OF HISTONE DEACETYLASE ABBOTT LABORATORIES (US) 2002-06-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020103192-A1 Inhibitors of histone deacetylase HDAC1, HDAC5, HDAC4 HDAC1 1/4885HDAC2 7/4885FFAR4 1771/4885
US-20020177594-A1 Inhibitors of histone deacetylase HDAC1, HDAC11, HDAC3 HDAC1 1/4885HDAC2 4/4885FFAR4 3816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.